logy, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 42.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in
Chugai Pharmaceutical, Japan. For more information: http://www.roche.com
SoftGenetics, LLC specializes in the development of genetic analysis tools for both research and diagnostic applications. Hallmarks of SoftGenetics software tools are advanced technologies, providing exceptional accuracy, and sensitivity in an easy to use Windows® user interface.
For life science research only. Not for use in diagnostic procedures.
454, 454 LIFE SCIENCES, and 454 SEQUENCING, and are trademarks of Roche.
The name "SoftGenetics," the SoftGenetics logo, NextGENe, and the NextGENe Condensation Tool are trademarks or registered trademarks of SoftGenetics, LLC.
All other product names and trademarks are the property of their respective owners.
For further information please contact:
Dr. Burkhard Ziebolz
454 Life Sciences Corporation, a Roche Company
Page: 1 2 3 Related biology technology :1
|SOURCE Roche Diagnostics GmbH|
Copyright©2010 PR Newswire.
All rights reserved
. Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide2
. 2 for 1: Simultaneous size and electrochemical measurement of nanomaterials3
. Kitty Castellini Wins Roche Diabetes Cares Diabetes Heroes Torchbearer Challenge4
. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)5
. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research6
. Electrochemistry controlled with a plasma electrode7
. Roche Licenses Nanopore Sequencing Technologies from Arizona State University and Columbia University for Rapid, Affordable DNA Sequencing8
. Roche NimbleGen Announces New Pre-capture Multiplexing for Target Enrichment Technology in Sequencing9
. Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment10
. Roche Submits Acute Hepatitis B Test to FDA for Premarket Approval11
. China Agri-Business Acquired Management and Operation Rights of Shaanxi Qinfeng Agrochemical Inc. in Xian, China